AI Fusion Capital Group
254A
Cookpad
2193
Shinko Electric Industries
6967
Btm
5247
eole
2334
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 46
- +1+2.22%
20min DelayMarket Closed Mar 28 15:30 JST
4.11BMarket Cap-2.53P/E (Static)
46High45Low338.60KVolume46Open45Pre Close15.55MTurnover8952wk High0.40%Turnover Ratio89.40MShares4152wk Low-16.51EPS TTM3.90BFloat Cap2229Historical HighLossP/E (Static)84.85MShs Float41Historical Low-18.21EPS LYR2.22%Amplitude--Dividend TTM3.29P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --